HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 16,040
+560 (3.62%)
Dec 30, 2025, 3:30 PM KST
-32.03% (1Y)
| Market Cap | 217.37B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 459.90 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 228,485 |
| Average Volume | 96,422 |
| Open | 15,400 |
| Previous Close | 15,480 |
| Day's Range | 15,170 - 16,350 |
| 52-Week Range | 12,500 - 33,250 |
| Beta | 0.49 |
| RSI | 58.03 |
| Earnings Date | Mar 20, 2026 |